Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 4516.12 | 653 / 653 | 99% | 29.10 | 597 / 605 |
brain | 100% | 3855.59 | 2634 / 2642 | 98% | 26.59 | 690 / 705 |
prostate | 100% | 3394.93 | 245 / 245 | 95% | 14.41 | 476 / 502 |
pancreas | 100% | 3448.52 | 328 / 328 | 91% | 8.43 | 162 / 178 |
bladder | 100% | 5473.05 | 21 / 21 | 81% | 9.17 | 410 / 504 |
kidney | 99% | 1938.58 | 88 / 89 | 82% | 6.92 | 735 / 901 |
esophagus | 99% | 2841.81 | 1435 / 1445 | 80% | 6.00 | 146 / 183 |
lung | 99% | 3036.74 | 575 / 578 | 79% | 6.27 | 913 / 1155 |
intestine | 100% | 5544.90 | 966 / 966 | 78% | 7.56 | 412 / 527 |
stomach | 100% | 3443.60 | 359 / 359 | 78% | 7.18 | 222 / 286 |
adrenal gland | 96% | 1899.32 | 247 / 258 | 75% | 7.79 | 172 / 230 |
breast | 100% | 2427.07 | 457 / 459 | 69% | 6.32 | 773 / 1118 |
skin | 93% | 1898.71 | 1680 / 1809 | 64% | 8.64 | 303 / 472 |
uterus | 100% | 2450.86 | 170 / 170 | 56% | 4.86 | 258 / 459 |
ovary | 98% | 1961.05 | 177 / 180 | 50% | 3.62 | 216 / 430 |
liver | 95% | 1454.20 | 215 / 226 | 30% | 1.74 | 122 / 406 |
muscle | 100% | 5611.02 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4380.04 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3962.27 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 2130.89 | 1195 / 1204 | 0% | 0 | 0 / 0 |
heart | 95% | 2475.10 | 815 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 76% | 7.46 | 22 / 29 |
peripheral blood | 76% | 1773.49 | 702 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 62% | 5.94 | 28 / 45 |
eye | 0% | 0 | 0 / 0 | 50% | 5.68 | 40 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006325 | Biological process | chromatin organization |
GO_0006338 | Biological process | chromatin remodeling |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0016363 | Cellular component | nuclear matrix |
GO_0016604 | Cellular component | nuclear body |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0016605 | Cellular component | PML body |
GO_0005634 | Cellular component | nucleus |
GO_0003690 | Molecular function | double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0043565 | Molecular function | sequence-specific DNA binding |
Gene name | SATB1 |
Protein name | DNA-binding protein SATB1 SATB homeobox 1 DNA-binding protein SATB1 (Special AT-rich sequence-binding protein 1) |
Synonyms | |
Description | FUNCTION: Crucial silencing factor contributing to the initiation of X inactivation mediated by Xist RNA that occurs during embryogenesis and in lymphoma (By similarity). Binds to DNA at special AT-rich sequences, the consensus SATB1-binding sequence (CSBS), at nuclear matrix- or scaffold-associated regions. Thought to recognize the sugar-phosphate structure of double-stranded DNA. Transcriptional repressor controlling nuclear and viral gene expression in a phosphorylated and acetylated status-dependent manner, by binding to matrix attachment regions (MARs) of DNA and inducing a local chromatin-loop remodeling. Acts as a docking site for several chromatin remodeling enzymes (e.g. PML at the MHC-I locus) and also by recruiting corepressors (HDACs) or coactivators (HATs) directly to promoters and enhancers. Modulates genes that are essential in the maturation of the immune T-cell CD8SP from thymocytes. Required for the switching of fetal globin species, and beta- and gamma-globin genes regulation during erythroid differentiation. Plays a role in chromatin organization and nuclear architecture during apoptosis. Interacts with the unique region (UR) of cytomegalovirus (CMV). Alu-like motifs and SATB1-binding sites provide a unique chromatin context which seems preferentially targeted by the HIV-1 integration machinery. Moreover, HIV-1 Tat may overcome SATB1-mediated repression of IL2 and IL2RA (interleukin) in T-cells by binding to the same domain than HDAC1. Delineates specific epigenetic modifications at target gene loci, directly up-regulating metastasis-associated genes while down-regulating tumor-suppressor genes. Reprograms chromatin organization and the transcription profiles of breast tumors to promote growth and metastasis. Promotes neuronal differentiation of neural stem/progenitor cells in the adult subventricular zone, possibly by positively regulating the expression of NEUROD1 (By similarity). . |
Accessions | C9JGL9 ENST00000457005.5 C9J3I0 ENST00000417717.6 [Q01826-2] ENST00000452260.6 ENST00000444341.1 C9IZC5 ENST00000457005.6 [Q01826-1] ENST00000700177.1 [Q01826-1] ENST00000450898.1 ENST00000700180.1 [Q01826-1] ENST00000493952.2 ENST00000700178.1 [Q01826-1] A0A1D5RMP0 ENST00000700179.1 [Q01826-1] ENST00000415069.5 A0A0B6XK52 H0YN86 C9JP21 ENST00000415069.6 [Q01826-1] ENST00000338745.11 [Q01826-1] C9JLL5 ENST00000454909.6 [Q01826-1] C9J7F3 Q01826 ENST00000440737.5 ENST00000414509.5 |